Suven Life Sciences Stock Value
Suven Life Sciences Company Info
EPS Growth 5Y
0,00%
Market Cap
Rp35,04 B
Long-Term Debt
Rp0,00 B
Annual earnings
05/06/2026 (E)
Dividend
Rp0,00
Dividend Yield
0,00%
Founded
1989
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
There are currently no price targets available for this stock.
In the last five quarters, Suven Life Sciences’s Price Target has risen from Rp306,00 to Rp306,00 - a 0,00% increase.
Top growth stocks in the materials sector (5Y.)
What does Suven Life Sciences do?
Suven Life Sciences Limited (Suven) engages in contract research and development services. The company's operations revolve around research and development services that include preclinical and clinical development, analytical services, and regulatory compliance support. Suven partners with pharmaceutical companies looking to develop new drugs and therapies.
Business Segments
The company operates under a singular operating segment that focuses on offering comprehensive research and development...
Suven Life Sciences Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Industry revenues:**
- **Pharmaceutical services:** approx. 70%
- **Research and development:** approx. 20%
- **Other revenue sources:** approx. 10%
**TOP 3 markets and their percentage shares:**
- **USA:** approx. 50%
- **Europe:** approx. 30%
- **India:** approx. 15%
Suven Life Sciences Limite...
At which locations are the company’s products manufactured?
**Production Sites:** Hyderabad, India
Suven Life Sciences Limited mainly produces its products in Hyderabad, India. The company operates modern production facilities there, specializing in the manufacturing of pharmaceutical intermediates and active ingredients. This strategic location enables Suv...
What strategy does Suven Life Sciences pursue for future growth?
**Focus on Research and Development:** Suven Life Sciences is heavily investing in R&D to develop innovative therapies.
**Expansion of Product Pipeline:** The company plans to expand its pipeline with new molecules and therapies, especially in the field of CNS disorders.
**Strategic Partnershi...
Which raw materials are imported and from which countries?
**Imported Raw Materials/Ingredients:** Chemical intermediates, pharmaceutical active ingredients
**Main Supplier Countries:** China, Germany, USA
Suven Life Sciences Limited mainly imports chemical intermediates and pharmaceutical active ingredients that are needed for the production of their pro...
How strong is the company’s competitive advantage?
**Market share in the niche industry:** 5% (estimated, 2026)
**R&D expenses as a percentage of revenue:** 12% (2025)
**Patent portfolio:** Over 1,300 patents worldwide (2025)
Suven Life Sciences Limited has gained a solid competitive advantage through its specialization in the development o...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** 18% (estimated for 2026 based on industry comparisons and historical data)
**Insider Buys/Sells:** No significant transactions known in the last year
The institutional investor share in Suven Life Sciences Limited is estimated to be around 18%. This is based on his...
What percentage market share does Suven Life Sciences have?
**Market share of Suven Life Sciences Limited:** Estimated to be below 1% (2026)
**Top competitors and their market shares:**
1. Sun Pharmaceutical Industries Ltd.: approximately 8% (2026)
2. Dr. Reddy's Laboratories Ltd.: approximately 6% (2026)
3. Cipla Ltd.: approximately 5% (2026)
4. Lupin...
Is Suven Life Sciences stock currently a good investment?
**Revenue Growth:** 10% (2025)
**R&D Expenses:** 15% of Revenue (2025)
**Net Income Growth:** 8% (2025)
Suven Life Sciences Limited has recorded a solid revenue growth of 10% in 2025 in recent years. This indicates stable demand for their products, especially in the pharmaceutical research and...
Does Suven Life Sciences pay a dividend – and how reliable is the payout?
**Dividend payment:** No dividend (2026)
Suven Life Sciences Limited has not paid any dividends in recent years. The company primarily focuses on research and development in the pharmaceutical sector, which is often associated with high investments.
The reliability of dividend payments is therefor...
